Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan
Mira Namba, Yudai Kaneda, Miho Iida · 2023
Read Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan by Mira Namba, Yudai Kaneda, Miho Iida (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714881.txt.
Description
Mira Namba, Yudai Kaneda, and Miho Iida question Japan's HPV vaccine dosing in a 2023 commentary. Uptake among girls crashed below one percent after safety fears, then climbed past thirty percent. In 2023, Japan allowed two doses for those first vaccinated under fifteen, keeping three doses for older starters. The authors argue the split owes as much to institutional caution as to proof.
Two doses already yield antibody conversion above ninety-nine percent in past reports, they note. One dose shows strong protection against the riskiest virus types at eighteen months. Keeping three doses for all older teens deserves a fresh look, they argue.
Catalog record
| CREATOR | Mira Namba, Yudai Kaneda, Miho Iida |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |